Axio BioPharma
PrivateLast Round
Pre Seed
Sep 21, 2026
Total Funding Raised
$2.45M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Axio BioPharma is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing by using AI to accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axio BioPharma Comparables
Compare Axio BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbInitio Bio | 73% | |
| Resilience | 70% | |
| Thermo Fisher Scientific Inc. | 69% |
Axio BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 21, 2026 | ||||
| Grant | Feb 3, 2026 | ||||
| Seed | Sep 2, 2025 |
Key People
Founding team and executive leadership
Axio BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Seed, Pre Seed |
| Chisos Capital | Seed, Pre Seed |
| BioForward Wisconsin | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
$2.4M raised from Chemical Angel Network and Chisos Capital.
- Aug 21, 2026
Monthly visitors increased 215% MoM, reaching 6.8K.
Recent news
Latest coverage and updates
- receives_financingSep 25, 2026
Axio BioPharma Inc. receives financing of $2.4M in Pre Seed.
- partners_withAug 10, 2026
Axio BioPharma Inc. partnered with The Bioforge on Aug 10th '26.
Axio BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axio BioPharma's valuation, stock price, and market status.
Is Axio BioPharma a public or private company?
Axio BioPharma is a private company.
What is the current stock price of Axio BioPharma?
Axio BioPharma is a private company with no public stock price. No recent secondary market data is available.
How much is Axio BioPharma worth (valuation)?
Valuation information for Axio BioPharma is not publicly available.
Can I buy Axio BioPharma stock?
Axio BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axio BioPharma's last funding round?
Axio BioPharma's most recent funding round was Seed on September 2, 2025.
Who are the main investors in Axio BioPharma?
Key investors in Axio BioPharma include Chemical Angel Network, Chisos Capital.
Will Axio BioPharma IPO soon?
No public IPO plans have been announced for Axio BioPharma.
How can I track Axio BioPharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axio BioPharma's secondary market activity and sign up for updates.